Have your say and contribute to the strategic research agenda for a Public-Private Partnership for Health Innovation under Horizon Europe!
23.10.19
Five industry associations representing pharmaceutical, biotech and medical technologies industries operating in Europe (COCIR, EFPIA, MedTech Europe, EuropaBio and Vaccines Europe) have come together to work on a Strategic Agenda for Innovation in Healthcare. This Agenda falls in the framework of the proposed European Health Innovation Public-Private Partnership (PPP) under Horizon Europe. Its objective is to guide future public-private research & innovation that would contribute – alongside other European research funding instruments - to addressing some key European healthcare challenges in an integrated manner.
Today, the private sector is interested to invest in a new health Public-Private Partnership and would like invite citizens, patients, health and research communities, national authorities, academia and scientific societies to provide their input to make sure that this Strategic Agenda:
- aligns with the needs of European health and research communities
- is both ambitious and feasible
- is clearly complementary with other European and national initiatives
Horizon Europe offers a thrilling opportunity to move to the next stage of innovation in healthcare, and contribute to improving European citizens’ health, strengthen health systems and create a thriving health R&D environment. It also offers further possibilities through the creation of institutionalised Public-Private Partnerships. The goal is to create a unique platform that does not exist anywhere else, a European multi-sector Partnership for health innovation. We strongly believe that by pioneering and de-risking multisector precompetitive collaboration we can together put Europe at the forefront of health innovation.
You have an opportunity to learn more about the proposed partnership and ask questions during a dedicated webinar on 4 November 14.00 CET – register here!
You can contribute to this consultation by filling in the online questionnaire until 24 November midnight.
If you are unable to use the online questionnaire, please send your contribution to contact@EUHealthPPP.org.
If you represent a company member of COCIR, EFPIA, EuropaBio, MedTech Europe, or Vaccines Europe please send your contribution to your respective trade association for traceability and faster processing, and to ensure proper representation:
COCIR: eberstein@cocir.org
EFPIA: magda.chlebus@efpia.eu
EuropaBio : B.Grimm@europabio.org
MedTech Europe: p.boisseau@medtecheurope.org
Vaccines Europe: anna.czwarno@vaccineseurope.eu